Complex Regional Pain Syndrome, Type I Clinical Trial
Official title:
A Randomized, Double-blind Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
This clinical trial is being conducted to demonstrate the efficacy of neridronic acid in the
treatment of pain associated with complex regional pain syndrome type I (CRPS-I).
The trial is divided into 3 periods: a 60-day enrollment period, a 12-week trial period, and
an extended follow-up period with visits at Month 6, Month 9, and Month 12. The extended
follow-up period will be terminated for all participants after the last participant enrolled
completes their Month 6 visit (Visit 9). The double-blind will be maintained throughout the
12-week trial period and extended follow-up period.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00817128 -
Pain Exposure Physical Therapy (PEPT) Versus CBO in Patients With Complex Regional Pain Syndrome Type I (CRPS-1)
|
Phase 2/Phase 3 | |
| Terminated |
NCT00109772 -
Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1
|
Phase 2 |